Table 2.

Summary of adverse events occurring in more than 5% of the treated set, n (%)

	Placebo N = 12	Empagliflozin 2.5 mg qd N = 9	Empagliflozin 10 mg qd N = 9	Empagliflozin 25 mg qd N = 9	Empagliflozin 100 mg qd N = 9
Patients with any AE	5 (41.7)	6 (66.7)	5 (55.6)	5 (55.6)	3 (33.3)
Headache	1 (8.3)	0	1 (11.1)	2 (22.2)	0
Diarrhea	1 (8.3)	2 (22.2)	0	0	0
Pruritus	1 (8.3)	1 (11.1)	0	1 (11.1)	0
Hypoglycemia	0	0	2 (22.2)	1 (11.1)	0

Data from the treated set (n = 48)

AE adverse event